Serum anti-müllerian hormone levels in healthy females: A nomogram ranging from infancy to adulthood

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4650-4655

  Lie Fong, S ^a   Visser, J A ^a   Welt, C K ^b   De Rijke, Y B ^a   Eijkemans, M J C ^c   Broekmans, F J ^c   Roes, E M ^a   Peters, W H M ^d   Hokken Koelega, A C S ^e   Fauser, B C J M ^c   Themmen, A P N ^a   De Jong, F H ^a   Schipper, I ^a   Laven, J S E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; ADULTHOOD; AGE; ARTICLE; CHILD; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE FERTILITY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INFANCY; MENSTRUAL CYCLE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGING; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIAGNOSTIC TECHNIQUES, ENDOCRINE; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; FEMALE; HEALTH; HUMANS; INFANT; INFANT, NEWBORN; MENSTRUAL CYCLE; MIDDLE AGED; NOMOGRAMS; REFERENCE VALUES; YOUNG ADULT;

EID: 84870729989     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1440     Document Type: Article

References (38)

1. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP 2004 Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10:77-83 (Pubitemid 38196508)
2. Andersen CY, Byskov AG 2006 Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. J Clin Endocrinol Metab 91:4064-4069 (Pubitemid 44536886)
3. Durlinger AL, Visser JA, Themmen AP 2002 Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124:601-609 (Pubitemid 35402334)
4. Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born BM, de Jong FH, Groome NP, Themmen AP, Visser JA 2006 Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 147:3228-3234 (Pubitemid 43901114)
5. La Marca A, Spada E, Grisendi V, Argento C, Papaleo E, Milani S, Volpe A 2012 Normal serum anti-Mullerian hormone levels in the general female population and the relationship with reproductive history. Eur J Obstet Gynecol Reprod Biol 163:180-184
6. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC 2002 Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77:357-362 (Pubitemid 34083560)
7. Pigny P, Jonard S, Robert Y, Dewailly D 2006 Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91:941-945 (Pubitemid 43357762)
8. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP 2002 Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17:3065-3071 (Pubitemid 35469254)
9. Lie Fong S, Baart EB, Martini E, Schipper I, Visser JA, Themmen AP, de Jong FH, Fauser BJ, Laven JS 2008 Anti-Mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online 16:664-670 (Pubitemid 351721736)
10. Fanchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J 2003 Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18:323-327 (Pubitemid 36236265)
11. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Fauser BJ, Themmen AP, te Velde ER 2005 Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 83:979-987
12. Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ 2011 AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update 17:46-54
13. Laven JS, Mulders AG, Visser JA, Themmen AP, DeJong FH, Fauser BC 2004 Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89:318-323 (Pubitemid 38183899)
14. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D 2003 Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88:5957-5962 (Pubitemid 38033078)
15. Almog B, Shehata F, Suissa S, Holzer H, Shalom-Paz E, La Marca A, Muttukrishna S, Blazar A, Hackett R, Nelson SM, Cunha-Filho JS, Eldar-Geva T, Margalioth EJ, Raine-Fenning N, Jayaprakasan K, McIlveen M, Wunder D, Freour T, Nardo LG, Balasch J, Peñarrubia J, Smeenk J, Gnoth C, Godehardt E, Lee TH, Lee MS, Levin I, Gamzu R, Tulandi T 2011 Age-related normograms of serum antimullerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril 95:2359-2363, 2363.e2351
16. Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, Cleemann L, Holm K, Gravholt CH, Andersson AM, Pedersen AT, Petersen JH, Linneberg A, Kjaergaard S, Juul A 2010 Serum levels of anti- Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 95:5003-5010
17. Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC 2008 Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab 19:340-347
18. Broer SL, Mol BW, Hendriks D, Broekmans FJ 2009 The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 91:705-714
19. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH 2011 A validated model of serum anti-mullerian hormone from conception to menopause. PLoS One 6:e22024
20. Lee JY, Jee BC, Lee JR, Kim CH, Park T, Yeon BR, Seo SY, Lee WD, Suh CS, Kim SH 2012 Age-related distributions of anti-Mullerian hormone level and anti-Mullerian hormone models. Acta Obstet Gynecol Scand 91:970-975
21. Adams JM, Taylor AE, Crowley Jr WF, Hall JE 2004 Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89:4343-4350 (Pubitemid 39244436)
22. Leunissen RW, Kerkhof GF, Stijnen T, Hokken-Koelega AC 2008 Fat mass and apolipoprotein E genotype influence serum lipoprotein levels in early adulthood, whereas birth size does not. J Clin Endocrinol Metab 93:4307-4314 (Pubitemid 352789526)
23. Murphy MK, Hall JE, Adams JM, Lee H, Welt CK 2006 Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab 91:3878-3884 (Pubitemid 44536858)
24. Roes EM, Sieben R, Raijmakers MT, Peters WH, Steegers EA 2005 Severe preeclampsia is associated with a positive family history of hypertension and hypercholesterolemia. Hypertens Pregnancy 24:259-271 (Pubitemid 41579636)
25. Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, teJong FH, teVelde ER 2003 The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18:700-706 (Pubitemid 36426945)
26. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar- Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456-488
27. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC 2006 PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113:1210-1217 (Pubitemid 44401217)
28. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ 2010 The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544-551
29. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R 2011 Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 24:223-227
30. Nelson SM, Messow MC, Wallace AM, Fleming R, McConnachie A 2011 Nomogram for the decline in serum antimullerian hormone: a population study of 9,601 infertility patients. Fertil Steril 95:736-741.e1-3
31. Shebl O, Ebner T, Sir A, Schreier-Lechner E, Mayer RB, Tews G, Sommergruber M 2011 Age-related distribution of basal serum AMH level in women of reproductive age and a presumably healthy cohort. Fertil Steril 95:832-834
32. te Velde ER, Pearson PL 2002 The variability of female reproductive ageing. Hum Reprod Update 8:141-154 (Pubitemid 34428965)
33. van Disseldorp J, Faddy MJ, Themmen AP, de Jong FH, Peeters PH, van der Schouw YT, Broekmans FJ 2008 Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab 93:2129-2134 (Pubitemid 351831526)
34. Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij IA, de Vet A, Themmen AP, Laven JS, de Jong FH, Te Velde ER, Fauser BC, Broekmans FJ 2011 Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 96:2532-2539
35. Freeman EW, Sammel MD, Lin H, Gracia CR 2012 Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 97:1673-1680
36. Rashidi BH, Abediasl Z, Tehraninejad ES, Shariat M, Mahdavi A 2009 Menstrual cycle length in relation to antimullerian hormone and follicle-stimulating hormone. J Reprod Med 54:315-318
37. Singer T, Barad DH, Weghofer A, Gleicher N 2009 Correlation of antimullerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril 91:2616-2619
38. Wachs DS, Coffler MS, Malcom PJ, Chang RJ 2007 Serum antimullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. J Clin Endocrinol Metab 92:1871-1874 (Pubitemid 46997202)